drugset / Trial / NCT01468272

Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old

NCT01468272

Phase 2 Completed 26 enrolled Chiesi Farmaceutici S.p.A.
RandomizedCrossoverOpen-labelTreatment

Summary

This is a pharmacokinetic comparison of CHF 1535 50/6 NEXT DPI versus the free combination of Beclomethasone DPI and Formoterol DPI in children (5 to 11 years old) of a formulation already approved in adults.

Timeline

Start
2011-11
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 24 ug Inhaled
Subject beclomethasone dipropionate Other / unclassified 200 ug Inhaled